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Abstract: The aim of the study is to study the clinical, anatomical and morphological features of 
malignant neoplasms of the cervix uteri in fertile and elderly women. The study is based on 
retrospective and prospective data from 60 patients with malignant cervical cancer. The disease is more 
common in 52.2-year-old women than in 35-39-year-olds and 60-64-year-olds. We can say that in 
83.3% of cases, women develop squamous cell carcinoma. It is in older women that this type of cancer 
develops into an endophyte, which complicates treatment and worsens the prognosis. 
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Introduction 
Relevance: Malignant tumors of the cervix are one of the most important problems of oncogynecology, 
ranking 3rd after malignant tumors of the breast and uterine body [1,7]. Cervical cancer morbidity and 
mortality are highest in Central-East Asia, Africa, and Latin America [4,9]. Each year, 500,000 women 
worldwide are diagnosed with cervical cancer for the first time, and nearly half of patients die [3,4,11]. 
In Uzbekistan, this figure is 5.8 per 100,000 population, and 3.9% of deaths after oncopathology [7]. 
This type of cancer is becoming one of the medical and social problems of developing countries [26,30]. 
Studies show that squamous cell carcinoma of the cervix is more common at the age of 34-36 years, and 
adenocarcinoma type at the age of 60-62 years [9]. The origin of the disease depends on several factors: 
age, reproductive status, menstrual and sexual function, social and political status, and others. statistical 
data show that cervical tumors occur in 30% of cases in the perimenopausal period, 25% in 30-40 years 
of age, and 20% in 60-70 years of age. Recently, the incidence of cervical cancer and precancerous 
lesions has increased significantly by the age of 30 years. [2,4]. Morbidity and mortality rates in 
developed countries are declining slightly as a result of preventive measures, but in socio-economically 
underdeveloped and developing countries, the rate remains high. [6,9]. In recent years, the disease has 
been on the rise among women of childbearing age. Therefore, European countries pay special attention 
to screening. Thus, the study of the age-specific clinical course of the disease in patients with cervical 
cancer, the definition of prognostic results and improving the effectiveness of treatment is a topical 
issue of clinical oncogynecology from a scientific and practical point of view [4,8,11 ]. 
Aim of the study: The purpose of this study is to study the clinical and morphological types, 
characteristics, convenient diagnostic methods, principles of adequate treatment and prognosis of 
malignant tumors of the cervix in women of different ages. 
Materials and methods: For primary histological verification of malignant cervical tumors in women of 
different ages, data were collected on the basis of retrospective and prospective data in 60 patients. 22 
(36.7%) patients with cervical cancer were women of childbearing age and 38 (63.3%) of which were 
older patients. The research was conducted on the basis of clinical indications and cyto-histological 
examinations. All patients are under control at the Bukhara Regional Oncology Center. 
Results: Studies have shown that malignant tumors of the cervix increase with age in women. It is 
characterized by extragenital diseases and systemic changes in the body with age. Another characteristic 
feature we have studied is that one in four women is diagnosed with a malignant tumor of the cervix due 
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to early marriage. It can be said that 83.3% of women develop squamous cell carcinoma. This is the 
morphological specificity of the sexual pathways. It is in older women that this type of cancer grows 
into an endophytic form, making treatment difficult and the prognosis poor. 
cervical pathology was indicated in all 60 patients in the two groups and in 10 (40%) patients in the 
control group (the data are fully reflected in the following material). In an objective gynecological 
study, the external genitalia were properly developed in all patients. The urethra, paraurethral tract, and 
large vaginal tract passed without pathological changes. The uterine size of all patients in the control 
group was correct and only 3 patients (12%) had a history of a slightly larger uterine size due to the 
greater weight of the newborn. According to UTT data, there was no pathology in the uterus. Residual 
manifestations of the inflammatory process were noted in 6 (24%) patients in the control group. 
As mentioned earlier, 37 (61.7%) patients in groups 1 and 2 had a history of cervical erosion and 
destructive treatment was used: electrocoagulation of the pathological part of the cervix in 27 (73%) 
patients and cryodestruction in 10 (27%) patients The study also examined the main indicators such as 
the nature and duration of menstruation, age of onset of sexual activity, first pregnancy, number of 
births and births, abortions, genital and extraganital diseases, with an emphasis on menstruation and 
reproductive activity in patients. The anamnesis findings of the examined women showed that they had 
experienced many diseases and surgeries in childhood, adolescence and middle age, and the 
examination of 38 women in group II revealed that 33 (86.8%) of them had infectious diseases in their 
teens. In group 1, 13 patients (59.1%) experienced infectious diseases. Of the 25 patients in the control 
group, 12 (48%) were infected in childhood infected with diseases. With extragenital diseases in the 
first place patients were shown to all study groups: 22 in 1 group 19 patients (86.3%); 
Of the 38 patients in group 2, 34 (89.5%) had a history of extragenital pathology; in the control group, 
this figure was seen in 9 (36%) of 25 patients. 
the examination revealed that 28 patients (46.7%) from groups 1 and 2 had genital pathology, half of 
which was a chronic inflammatory process of the genitals. More specifically, they had inflammatory 
diseases of the genitals diagnosed before the underlying disease was identified. Information on 
infectious-inflammatory diseases experienced by patients is given in Table 1. 
Table №1 
Infectious inflammation experienced by patients diseases 
diseases I group (n=22)   II group (n=38)   
 relative % relative  % 
endocervicitis 1 4,5% 7 18,4% 
cervical erosion  2 9% 4 10,5% 
chronic endometritis 
 




















- - 1 2,6% 
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26 patients (43.3%) in both groups had a history of pre-existing cervical pathology. Analysis of 
menstrual function showed that the mean age of menarche in the examined women was 15.5 ± 3.5 
years, ranging from 12 to 16 years. Menarche at the age of 12-14 years was observed in 35 patients 
(58.3%), 18 (30%) patients at the age of 15 years and older, and early menstruation in 7 patients 
(11.7%). Thus, in 45% of the examined patients, changes in menstrual function were observed, which 
led to disorders of the hypothalamus - pituitary - ovarian - uterine system during puberty. In 36 patients 
(60%) menstruation was observed with moderate bleeding during sexual development, in 12 patients 
(20%) was observed heavy bleeding, in 6 patients (10%) was observed minor bleeding, and in 6 patients 
(10%) was painful menstrual bleeding. condition was observed. During the life of a woman, especially 
in reproductive age, the nature of menstrual bleeding changed, in 42 (70%) patients menstruation was 
observed with excessive bleeding and blood clots, which lasted more than ten days, ie hypermenstrual 
syndrome. again, it is interesting to note that in 21 (35%) women, irregular and heavy blood loss 
menstruation was observed on average 2.2 years before the onset of the average gynecological 
pathology. Once gynecological pathology was identified, this pathological process became more 
pronounced in 58% of patients. The majority of those examined were related to the gynecological 
pathology in which the nature of menstruation occurred. Menstruation was accompanied by heavy 
bleeding, acyclic and painful. 
analysis of reproductive function showed that in the first group, primary infertility was detected in 2 
(9%) and secondary infertility in 3 (13.6%) patients. In the anamnesis of 5 (22.7%) patients, 1 to 6 
abortions were observed. 4 patients (18.2%) and 5 women (22.7%) with a history of more than 3 births 
under observation performed 1 to 5 abortions. Thus, the anamnesis of women who did not require 
operative practice had a high number of artificial and spontaneous abortions. In the second group, there 
were 11 (28.9%) women with primary and secondary infertility. 
 Table №2 
Background diseases of CC in both groups 
bBO background diseases young  all  
18-49 >49 Relative % 
Relative % Relative % 
No 2 9,1% 5 13,2% 7 11,7% 
no card 2 9,1% 2 5,2% 4 6,7% 
real erosion 5 22,7% 9 23,7% 14 23,3% 
pseudoerosion 2 9,1% 3 7,9% 5 8,3% 
endocervicitis 7 31,8% 11 28,9% 18 30% 
leukoplakia 3 13,6% 5 13,1% 8 13,3% 
cervical polyp 1 4,5% 3 7,9% 4 6,7% 
 
 
the table shows that the incidence of cervical inflammatory diseases in postmenopausal women was 
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28.9% and in women of reproductive age 31.8%. The incidence of endocervicitis in older women is 
associated with thinning of the endocervical epithelium, a decrease in the number of glands. At this age, 
the thin epithelium is easily injured. All this is due to the low production of ovarian hormones in older 
women, a violation of the self-cleansing process of the vagina due to low levels of glycogen in the 
epithelium. Leukoplakia and cervical polyps are about 2 times more common in older women than in 
women of childbearing age. In women of reproductive age, erosions are the main background honey. 
Table 3 describes gynecological surgeries performed in both groups of women. 
Table №3 
Anamnestic data on gynecological operations 
gynecological operations Young All  
18-49 >49 Relative % 
Relative % Relative % 
No 2 9,1% 5 13,2% 7 11,7% 
operations on uterine 
excess 
1 4,5% 2 5,2% 3 5% 
Cervical coagulation 15 68,2% 22 57,9% 37    61,7% 
Cervical congestion 4 18,2% 9 23,7% 13 21,6% 
Total 22 100% 38 100% 60 100% 
 
cervical surgeries were performed less frequently in adults of childbearing age. The main complaints of 
patients before surgery: bleeding (64%), of which 33 (55%) periodic, 27 (45%) non-periodic bleeding, 
pain (35-35%), signs of constriction of neighboring organs (32%). In 8 (8%) patients with cervical 
cancer, the disease passed without clinical signs, only because of the size of the tumor they underwent 
surgery. 
The results of the analysis showed that the clinical, colposcopic and morphological features used in the 
detection of cervical pathology in 2 groups of patients helped to identify the symptoms of a specific 
nosological form of the disease. Chronic cervicitis and cervical retention cysts were found to be mainly 
due to disruption of the epithelialization process. In some cases, cervical leukoplakia (group 1 - 60%, 
group 2 - 40%, control group - 33.3%) was also detected. It has been found that this leukoplakia is 
mainly due to the fact that cervical pathology has been treated extensively before. It is also noteworthy 
that CIN I-II was detected in 5 (27.8%) patients and cervical cancer in 1 (5.5%) patients. It should be 
noted that every second patient has cervical pathology with another disease. For example, leukoplakia is 
associated with ectropion disease, cervical deformity, chronic cervicitis, endometriosis. 
the study showed that the tumor was localized in the cervical canal in only 7 (11.7%) patients, and that 
the tumor covered the cervical ectocervix in 53 (88.3%) patients. As a result, the majority of patients 
presented with complaints specific to cervical cancer (contact bleeding or bleeding from a ruptured 
cervical tumor). It should be noted that in patients over 60 years of age, 83% of the tumor is located in 
the ectocervix and 17% in the cervical canal. In patients under 45 years of age, cervical canal cancer 
was found to be 2 times less common (8.8%) and more common (91.2%) in the ectocervix. In all 
patients, the clinical diagnosis was confirmed by histological examination. 
Table № 4 
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Histological structure of CCs 
histological structure Young Total 
18-49 young 49 older than 
smooth-celled branched 12 54,5% 17 44,7% 29 48,3% 
smooth cell unbranched 5 22,7% 7 18,4% 12 20% 
low differentiated 1 4,5% 4 10,5% 5 8,3% 
adenocarcinoma 4 18,2% 9 23,7% 13 21,7% 
glandular smooth cell - - 1 2,6% 1 1,7% 
Total 22 100% 38 100% 60 100% 
Table 4 shows the proportion of histological types of tumors in the study groups. Overall, 70% of the 
tumors in both study groups were smooth-cell carcinomas, of which 69% were smooth-celled 
carcinomas, 28.6% were smooth-celled carcinomas, and 2.4% were glandular smooth-cell carcinomas. 
In 30% of cases, low-differentiated and adenocarcinoma cell tumors were formed. Table 5 shows the 
degree of differentiation of CCs in women of different ages. 
                                                                                                                                  Table №5 
Level of differentiation of CCs 
degree Young Total 
18-49 young 49 older than 
high 13 59% 21 55,3% 34 56,7% 
middle 6 27,4% 11 28,9% 17 28,3% 
Low 3 13,6% 6 15,8% 9 15% 
Total 22 100% 38 100% 60 100% 
 
it can be said that the majority of patients with cervical cancer had a high rate (56.7%) of cancer in both 
the primary and comparative groups. In both groups, low-grade cancer was less common, but it was 
almost twice as common in patients over 60 years of age. 
Conclusion 
When analyzing the literature, we see that the cervix is a hormone-requiring organ, just like the uterus 
itself, and that pathological changes indicate a common pathogenetic mechanism based on development. 
But from an anatomical and functional point of view, the cervix is an autonomous organ, so the 
pathology that develops in them, especially gynecological pathologies, has not been fully studied to 
date. In particular, the structure of cervical disease in patients with cervical problems after subtotal 
hysterectomy has not been fully studied in patients with cervical disease who have not been treated 
surgically with dispensary control. The efficacy of cervical treatments and the principles of post-
treatment rehabilitation have also not been established. The above method of research with its high 
qualities is considered to be one of the advanced methods with diagnostics. However, the method of 
morphological study of cervical biopsy is the decisive method, if indicated in the diagnosis. 
studies have shown that cervical tumors increase with age, averaging + -52.2 years. Concentrations of 
35-39 are less common in women aged 60-64. From the characteristic factors we studied, it became 
clear that every woman who got married early was more likely to develop this type of tumor. 53.5% of 
all women in the test had a highly differentiated type of sarcoma. 
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In older women, cervical cancer is more common and complicated, and post-treatment side effects 
include deep invasion of the cervix 1 cm or more, complete damage to the vaginal part of the cervix, 
anatomical growth of the tumor, and more metastasis to regional lymph nodes. Therefore, it is necessary 
to introduce early clinical and diagnostic examinations of women in age groups in primary care 
institutions and screening examinations in family clinics. 
 
References: 
1. Аксель Е.М., Т.И. Ушакова. Статистика злокачественных новообразований у пожилых. 
//Материалы Европейской школы по онкологии "Рак у пожилых: достижения и 
перспективы"- Москва, 19-20 ноября, 2001 г. 
2. Аксель Е.М. Статистика злокачественных новообразований женской половой сферы. 
Онкогинекология 2012; 1: 18—23. 
3. Анализ результатов хирургического лечения рака шейки матки пациенток фертильного 
возраста -В.С. Наврузова Республиканский онкологический научный центр Министерства 
здравоохранения Республики Узбекистан.2015й 
4. Горобцова В.В., Ковалев А.А. Рак шейки матки: актуальность проблемы, принципы 
лечения. // Главный врач Юга России. 2016; 1 (48): 63–66. 
5. Джемал А., Винеис П., Брей Ф., Торре Л., Форман Д. (редакция) Атлас по онкологии. 
Издание второе. – Атланта, штат Джорджия: Американское онкологическое общество, 
2014 г.  
6. Левшин В.Ф., Завельская А.Я. Факторы риска и профилактика рака шейки матки. // Вопр. 
онкологии. 2017; 63 (3): 506–16. 
7. Н.Ш. Юлдашева, В.С. Наврузова Рак шейки матки.(монография). Тошкент-2014;8-64. 
8. 8.Новик В.И. Эпидемиология рака шейки матки, факторы риска, скрининг // Практическая 
онкогинекология: Избранные лекции / Под редакцией У.Ф. Урманчеевой, С.А. 
Тюляндина, В.М. Моисеенко. – Санкт-Петербург: Центр ТОММ, 2008. – С. 101-115.  
9. Cаидов Г.Н., Абдукаримов У.Г., Махмудова Г.Ф.// Эпидемиологические показатели 
первично-множественных опухолей// Биология и интегративная медицина// Бухара.-№11-
(39)11.2019.-С31-42. 
10. Cibas ES, Ducatman BS.Cervical and vaginal cytology.Cytology.Diagnostic principles and 
clinical correlations. Saunders Elsevier 2009. 
11. Elliott P., Coppleson M., Russell P. et al. Early invasive (FIGO stage IA) carcinoma of the 
cervix: a clinico-pathologic study of 476 cases. // Int J Gynecol Cancer. – 2000. –V. 10, N 1. – 
P. 42–52. 
12. KurmanRJ.,Carcangiu ML., Harrington CS., Young RH, eds. WHO Classification of Tumors of 
the Female Reproductive Organs. Geneva, Switzerland: WHO Press; 2014.World Health 
Organization Classification of Tumors. 4th edition. 
13. Marlow LA, Waller J, Wardle J. Barriers to cervical cancer screening among ethnic minority 
women: a qualitative study. J FamPlannReprod Health Care 2015; 41 (4): 248–54. 
 
 
 
 
